NO770804L - ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE AMINOALYL HETEROCYCLIC COMPOUNDS - Google Patents

ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE AMINOALYL HETEROCYCLIC COMPOUNDS

Info

Publication number
NO770804L
NO770804L NO770804A NO770804A NO770804L NO 770804 L NO770804 L NO 770804L NO 770804 A NO770804 A NO 770804A NO 770804 A NO770804 A NO 770804A NO 770804 L NO770804 L NO 770804L
Authority
NO
Norway
Prior art keywords
aminoalyl
preparation
therapeutically active
heterocyclic compounds
analogical procedure
Prior art date
Application number
NO770804A
Other languages
Norwegian (no)
Other versions
NO147950C (en
NO147950B (en
Inventor
Anton Mentrup
Kurt Schromm
Ernst-Otto Renth
Richard Reichl
Werner Traunecker
Wolfgang Hoefke
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO770804L publication Critical patent/NO770804L/en
Publication of NO147950B publication Critical patent/NO147950B/en
Publication of NO147950C publication Critical patent/NO147950C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Laminated Bodies (AREA)
  • Nonwoven Fabrics (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO770804A 1976-03-09 1977-03-08 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE AMINOAL COOL-HETEROCYCLIC COMPOUNDS NO147950C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762609645 DE2609645A1 (en) 1976-03-09 1976-03-09 AMINOALKYLHETEROCYCLES

Publications (3)

Publication Number Publication Date
NO770804L true NO770804L (en) 1977-09-12
NO147950B NO147950B (en) 1983-04-05
NO147950C NO147950C (en) 1983-07-13

Family

ID=5971857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770804A NO147950C (en) 1976-03-09 1977-03-08 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE AMINOAL COOL-HETEROCYCLIC COMPOUNDS

Country Status (36)

Country Link
US (4) US4154829A (en)
JP (2) JPS52108970A (en)
AT (1) AT360542B (en)
AU (1) AU515953B2 (en)
BE (1) BE852223A (en)
BG (4) BG28051A4 (en)
CA (1) CA1086317A (en)
CH (8) CH630358A5 (en)
CS (2) CS220320B2 (en)
DD (1) DD130037A5 (en)
DE (1) DE2609645A1 (en)
DK (1) DK102177A (en)
ES (10) ES456622A1 (en)
FI (1) FI69070C (en)
FR (2) FR2343731A1 (en)
GB (1) GB1571231A (en)
GR (1) GR64553B (en)
HK (1) HK12884A (en)
HU (1) HU177953B (en)
IE (1) IE45300B1 (en)
IL (1) IL51627A (en)
LU (1) LU76898A1 (en)
MX (1) MX4878E (en)
MY (1) MY8500079A (en)
NL (1) NL7702403A (en)
NO (1) NO147950C (en)
NZ (1) NZ183536A (en)
PH (3) PH16110A (en)
PL (2) PL112937B1 (en)
PT (1) PT66282B (en)
RO (3) RO79706A (en)
SE (1) SE435059B (en)
SG (1) SG55583G (en)
SU (4) SU698530A3 (en)
YU (1) YU62377A (en)
ZA (1) ZA771412B (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES
DE2644833A1 (en) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE AMINOPROPANES AND METHOD FOR THE PRODUCTION THEREOF
DE2833140A1 (en) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim NEW N-SUBSTITUTED HETEROCYCLES
BE883069A (en) 1979-05-04 1980-08-18 Continental Pharma PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND USE AS WELL AS A COMPOSITION CONTAINING THESE DERIVATIVES.
DE3026534A1 (en) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-BENZOXAZINE-2-ONE, THEIR PRODUCTION AND USE
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
DE3325875A1 (en) * 1983-07-18 1985-01-31 Boehringer Ingelheim KG, 6507 Ingelheim NEW 1-PHENYLIMIDAZOLIDIN-2-ON DERIVATIVES, THEIR PRODUCTION AND USE
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
TW203049B (en) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
US6075040A (en) 1996-09-05 2000-06-13 Eli Lilly And Company Selective β3 adrenergic agonists
ES2171839T3 (en) 1996-09-05 2002-09-16 Lilly Co Eli CARBAZOL ANALOGS AS BETA3 SELECTIVE ADRENERGIC AGONISTS.
CO5011072A1 (en) 1997-12-05 2001-02-28 Lilly Co Eli ETANOLAMINAS PIRAZINIL SUBSTITUTED AS AGFONISTS OF THE RECEPTORS
MXPA03009602A (en) * 2001-04-18 2004-04-02 Euro Celtique Sa Nociceptin analogs.
SI1975164T1 (en) 2001-04-18 2010-05-31 Euro Celtique Sa Octahydrobenzimidazolone compounds as analgetics
EP1385515B1 (en) 2001-04-18 2008-08-06 Euro-Celtique S.A. Spiropyrazole compounds
PT1598340E (en) * 2001-04-18 2009-04-13 Euro Celtique Sa 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
US6828440B2 (en) 2001-04-18 2004-12-07 Euro-Celtique, S.A. Spiroindene and spiroindane compounds
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
MXPA05005661A (en) * 2002-11-27 2005-11-23 Artesian Therapeutics Inc COMPOUNDS WITH MIXED PDE-INHIBITORY AND beta-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE.
JP2006513222A (en) * 2002-12-23 2006-04-20 アルテシアン セラピューティック，インコーポレイティド Cardiotonic compounds with inhibitory activity against adrenergic beta receptors and phosphodiesterases
DE102004001413A1 (en) * 2004-01-09 2005-08-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-hydroxymethyl-4-hydroxy-phenyl derivatives for the treatment of chronic obstructive pulmonary disease
DE102004003428A1 (en) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-2 agonists, and their use as pharmaceuticals
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
DE102004021779A1 (en) * 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
DE102004045648A1 (en) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg New betamimetics for the treatment of respiratory diseases
EP1830852A2 (en) * 2004-11-30 2007-09-12 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
EP1833480A2 (en) * 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
DE102005007654A1 (en) * 2005-02-19 2006-08-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting betamimetics for the treatment of respiratory diseases
DE102005030733A1 (en) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient
ES2530991T3 (en) * 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedure for obtaining betamimetics
DE102005052102A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
DE102005052101A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, process for their preparation and their use as medicines
DE102005052127A1 (en) * 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel indole beta-agonists, process for their preparation and their use as pharmaceuticals
EP1986644A1 (en) * 2006-02-16 2008-11-05 Boehringer Ingelheim International GmbH Drug combinations for the treatment of respiratory tract diseases
PE20080142A1 (en) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int ENANTHOMERICALLY PURE BETA-AGONISTS AND THEIR PREPARATION PROCEDURES
DE502007006951D1 (en) 2006-08-07 2011-05-26 Boehringer Ingelheim Pharma MEDICINAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
US8686008B2 (en) * 2007-08-16 2014-04-01 The University Of Mississippi Highly selective sigma receptor ligands
US9604926B2 (en) 2007-08-16 2017-03-28 The University Of Mississippi Highly selective sigma receptor radioligands
US8809381B2 (en) * 2007-08-16 2014-08-19 The University Of Mississippi Highly selective sigma receptor ligands

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA631296A (en) * 1961-11-21 L. Clark Robert Substituted benzimidazolones
CH149009A (en) * 1929-08-10 1931-08-15 Chem Ind Basel Process for the preparation of an N-substituted compound of the pyridone series.
US2857394A (en) * 1957-05-10 1958-10-21 Ciba Pharm Prod Inc Heterocyclic compounds
NL284529A (en) * 1961-10-24
FR1516714A (en) * 1962-11-07 1968-02-05 Bayer Ag Process for preparing imidazolidine derivatives
FR1384708A (en) * 1963-11-21 1965-01-08 Thomson Houston Comp Francaise Improvements to devices for placing objects
BE659364A (en) * 1964-02-05
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
FR1573739A (en) * 1968-07-26 1969-07-04
US3984405A (en) * 1971-06-28 1976-10-05 E. R. Squibb & Sons, Inc. Anti-inflammatory agents
BE787103A (en) * 1971-08-04 1973-02-02 Pfizer NEW PROPANOLAMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING
FR2168140A1 (en) * 1972-01-17 1973-08-31 Bellon Labor Sa Roger Dihydro-benzoxazine derivs - antidepressants
US3925383A (en) * 1972-12-08 1975-12-09 Janssen Pharmaceutica Nv Bicyclic imidazoles and pyrimidines
US3994901A (en) * 1974-06-13 1976-11-30 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-hydroxy-3,4-dihydrocarbostyril derivatives
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES

Also Published As

Publication number Publication date
FI770586A (en) 1977-09-10
ES466606A1 (en) 1978-10-01
IL51627A (en) 1980-10-26
RO70569A (en) 1981-11-24
MY8500079A (en) 1985-12-31
PL196505A1 (en) 1979-06-18
US4215119A (en) 1980-07-29
SU698530A3 (en) 1979-11-15
ES466605A1 (en) 1978-10-01
BG28052A4 (en) 1980-02-25
ATA122377A (en) 1980-06-15
FR2343731B1 (en) 1982-02-26
GB1571231A (en) 1980-07-09
AT360542B (en) 1981-01-12
SU685149A3 (en) 1979-09-05
BG28051A4 (en) 1980-02-25
HU177953B (en) 1982-02-28
DE2609645A1 (en) 1977-09-15
IE45300B1 (en) 1982-07-28
JPS52108970A (en) 1977-09-12
FR2372810A1 (en) 1978-06-30
CA1086317A (en) 1980-09-23
US4271158A (en) 1981-06-02
SE435059B (en) 1984-09-03
LU76898A1 (en) 1978-06-01
CS209435B2 (en) 1981-12-31
CH630364A5 (en) 1982-06-15
SU683616A3 (en) 1979-08-30
AU2300977A (en) 1978-09-14
US4154829A (en) 1979-05-15
PH16110A (en) 1983-06-30
SE7702609L (en) 1977-10-11
ES466603A1 (en) 1978-10-01
ZA771412B (en) 1978-11-29
ES466602A1 (en) 1978-10-01
SG55583G (en) 1984-07-27
US4363814A (en) 1982-12-14
FI69070C (en) 1985-12-10
CH630358A5 (en) 1982-06-15
CH630363A5 (en) 1982-06-15
ES466600A1 (en) 1978-10-01
FR2372810B1 (en) 1982-11-26
GR64553B (en) 1980-04-14
ES466599A1 (en) 1978-10-01
ES466601A1 (en) 1978-10-01
PH17635A (en) 1984-10-18
NO147950C (en) 1983-07-13
HK12884A (en) 1984-02-24
NL7702403A (en) 1977-09-13
ES456622A1 (en) 1978-03-16
CH630362A5 (en) 1982-06-15
PH16149A (en) 1983-07-12
CH630359A5 (en) 1982-06-15
RO79706A (en) 1982-08-17
MX4878E (en) 1982-11-26
SU676163A3 (en) 1979-07-25
BE852223A (en) 1977-09-08
ES466604A1 (en) 1978-10-01
BG28053A4 (en) 1980-02-25
YU62377A (en) 1982-10-31
NZ183536A (en) 1981-11-19
JPS6172A (en) 1986-01-06
FI69070B (en) 1985-08-30
CH630360A5 (en) 1982-06-15
AU515953B2 (en) 1981-05-14
PL111240B1 (en) 1980-08-30
CH630361A5 (en) 1982-06-15
RO76589A (en) 1981-04-30
ES466598A1 (en) 1978-10-01
PT66282A (en) 1977-04-01
FR2343731A1 (en) 1977-10-07
NO147950B (en) 1983-04-05
IE45300L (en) 1977-09-09
DK102177A (en) 1977-09-10
IL51627A0 (en) 1977-05-31
CH630365A5 (en) 1982-06-15
PT66282B (en) 1979-01-17
DD130037A5 (en) 1978-03-01
PL112937B1 (en) 1980-11-29
CS220320B2 (en) 1983-03-25
BG27743A3 (en) 1979-12-12

Similar Documents

Publication Publication Date Title
NO770804L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE AMINOALYL HETEROCYCLIC COMPOUNDS
NO823274L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE BIS-PYRIDINIUM ALKANE COMPOUNDS
NO784397L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PHTALAZIN-4-YL-ACTIC ACID DERIVATIVES
NO773384L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 1-ARYLOXY-2-HYDROXY-3-ALKYLENAMINOPROPANE DERIVATIVES
NO147243C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHTALAND DERIVATIVES
SE431088B (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZYDRYLSULPHINYL DERIVATIVES
NO147450C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CHINAZOLONE DERIVATIVES
NO780883L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE 4-ACYLAMINO-PHENYL-ETHANOLAMINES
SE431646B (en) PROCEDURE FOR THE PREPARATION OF ACYLAMINOSUBSTITUTED FIVE-LEADED HETEROCYCLIC NITROGEN COMPOUNDS
NO151040C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 5-HALOGENPYRIMID-2-ONES
NO147953C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE ANTHRACYCLING GLOSOSIDES
NO781880L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE BENZODIAZEPIN DERIVATIVES
NO145762C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE ANTRACYCLING GYCOSIDIC COMPOUNDS
NO145842C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE INDOLICINE DERIVATIVES
NO150081C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE DERIVATIVES OF PERHYDRO-AZA HETEROCYCLES
NO150605C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRIDINYL AMINOAL COOLETERS
NO834363L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE SESQUITER PENDER DERIVATIVES
NO792139L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE THIZOLOXAMIC ACID DERIVATIVES
NO772329L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE IMIDAZOLINE DERIVATIVES
NO781878L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRIDOBENZODIAZEPINES.
NO781879L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PYRIDOBENZODIAZEPINES
SE433081B (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE COMPOUNDS
NO151285C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DI-O-N-ALKYL-GLYCEROLD DERIVATIVES
NO148291C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BASIC SUBSTITUTED THEOPHYLININE DERIVATIVES
NO148454C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDINE-DIONE DERIVATIVES